Identification of Hypoxanthine as a Urine Marker for Non-Hodgkin Lymphoma by Low-Mass-Ion Profiling

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-10-55
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Non-Hodgkin Lymphoma

2020English

Bendamustine-Based Therapy as First-Line Treatment for Non-Hodgkin Lymphoma

Medical Oncology
MedicineCancer ResearchOncologyHematology
2014English

Leptospirosis in a Case of Non-Hodgkin Lymphoma

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2010English

Occurrence of Sarcoidosis After Chemotherapy for Non-Hodgkin Lymphoma

Korean Journal of Internal Medicine
Internal Medicine
2016English

Constitutive Overexpression of a Novel 21 kDa Protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2008English

Studies Identify Non-Hodgkin Lymphoma Suppressor

Cancer Discovery
Oncology
2015English

Epidemiology and Etiology of Non-Hodgkin Lymphoma – A Review

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2006English

Fluorine-18 Fluorodeoxyglucose PET-CT for Extranodal Staging of Non-Hodgkin and Hodgkin Lymphoma

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2014English

Quality of Life Among Non-Hodgkin Lymphoma Survivors

Zaporozhye Medical Journal
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy